InvestorQ : How do you see Cipla as a stock in the light off the recent developments in the COVID-19 medications effort by the company?
sara Kunju made post

How do you see Cipla as a stock in the light off the recent developments in the COVID-19 medications effort by the company?

Answer
image
1 year ago
Follow

In fact, the strong domestic focus and its progress on COVID-19 make Cipla one of the best pharma bets in India for investment. Cipla has sought approval from Indian regulators to launch experimental Coronavirus drug Favipiravir in India for treatment of COVID-19. Under the guidance of ICMR, Cipla will conduct limited trials prior to marketing the product as Ciplenza. Globally many drugs are under clinical trials on Coronavirus patients to establish their efficacy against Covid-19. In India, CSIR has identified the top 25 drugs for repurposing. Among these top 25 drugs, Favipiravir has emerged as of one of the most promising drugs and that should be a big boost for Cipla. It has already approached the DCGI for approval for Favipiravir to be launched in India as a generic drug.

3 Views